medigraphic.com
ISSN 0035-0052 (Print)

2001, Number 2

<< Back Next >>

Rev Mex Pediatr 2001; 68 (2)

Spine muscle atrophy Type I. A report of an atypical case

Garza AAG, Rodríguez BR, López EJA, Nieto SA

Language: Spanish
References: 25
Page: 69-71
PDF size: 67.27 Kb.


ABSTRACT

Type I spinal muscular atrophy is a degenerative illness of the motoneurons from the anterior portion of the spinal cord, the damage is initiated during fetal life affecting the proximal voluntary muscles, without the compromise of sensibility. There are 4 typical histopatological features and a characteristic clinical presentation that is not patognomonic.
None typical signs are seen in 15% of patients. The diagnosis is made by laboratory and radiological workup. An effective treatment does not exist, and its prognosis is very poor. We present a case considered atypical.


REFERENCES

  1. Birnkrant DJ, Pope JF, Martin JE, Repucci AH. Treatment of type I Spinal Muscular Atrophy with noninvasive ventilation and gastrostomy feeding. Pediatr Neurol 1998; 18: 407-10.

  2. Bach JR, Wang TG. Noninvasive long-term ventilatory support for individuals with spinal muscular atrophy and functional bublbar musculature. Arch Phys Med Rehabil 1995; 76: 213-7.

  3. Pérez A, Mullot R, Vardon G. Thoracoabdominal pattern of breathing in neuromuscular disorder. Chest 1996; 110: 454-61.

  4. Chou SM, Wang HS. Aberrant glycosilation/phosphorylation in chromatolytic motoneurons of Werdning- Hoffmann disease. J Neurol Sci 1997; 25(152): 198-209.

  5. MacLean Md, Roy N, MacKenzie AE. Two 5q13 simple tandem repeat loci are in linkage disequilibrium with type I spinal muscular atrophy. Hum Mol Genet 1994; 3: 1951-6.

  6. Parsons DW, McAndrew PE, Monani UR. An II base pair duplication in exons 6 of the SMN gene prodeces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. Hum Mol Gen 1996; 5: 1727-32.

  7. Yaamanouchi Y, Yaamanouchi H, Becker LE. Synaptic alterations of anterior horn cells in Werdning-Hoffmann disease. Pediatric Neurol 1996; 15: 32-5.

  8. Burlet P, Burglen L. Large scale deletions of the 5q13 region are specific to Werdning-Hoffmann disease. J Med Genet 1996; 33: 281-3.

  9. Ohkura M, Mitsudome A, Yasumoto S. Werndnig-Hoffmann disease type I with progressive ophthalmoplegia and ptosis. No To Hattatsu 1996; 28: 332-5.

  10. Baumgarther MR, Verhoeven NM, Jakobs C. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdning-Hoffmann disease. Neurology 1998; 51: 1427-32.

  11. Vajsar J, Balslev T, Ray PN. Congenital cytoplasmic body myopathy with survival motor neuron gene deletion or Werdning-Hoffmann disease. Neurology 1998; 51: 873-5.

  12. Colomer J. Childhood spinal muscular atrophies. Neurologia 1996; 11(Suppl 5): 29-42.

  13. Lefebver S, Burglen L, Frezal J. The role of the SMN gene proximal spinal muscular atrophy. Hum Mol Genet 1998; 7: 1531-6.

  14. Iannaccone ST. Spinal muscular atrophy. Semin Neurol 1998; 18: 19-26.

  15. Zerres K, Rudnik-Shoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modifications of existing classifications. Arch Neurol 1995; 52: 518-23.

  16. Melki J, Sheth P, Abdelhak S, Burlet P. Mapping of acute (type I) spinal muscular atrophy to chromosome 5ql2-ql4. The French Spinal Muscular Atrophy Investigators. Lancet 1990; 336: 271-3.

  17. Salhi MA, Mahdi AH, Jarallah AS. Childhood neuromuscular disorders: a decade’s experience in Saudi Arabia. Ann Trop Pediatric 1996; 16: 271-80.

  18. Rudnik-Schoneborn S, Forkert R. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletions findings. Neuropediatrics 1996; 27(1): 8-15.

  19. Spiegel R, Hagman A, Bolthauser E. Molecular genetic diagnosis and deletions analysis in type I-III spinal muscular atrophy. Schweiz Med Wochenschr 1996; 126(21): 907-14.

  20. Behrman: Nelson. Textbook of Pediatrics 15th ed. Chapter 563: 1757-1758.

  21. Farreras. Tratado de Medicina Interna l4ª ed. 2000, Editorial Harcourt-Brace.

  22. Otero-Siliceo E, Arriada-Mendicoa N, Corona-Vázquez T. Frequency of motor neuron disease in a Mexico City referral center. Rev Invest Clin 1997; 49: 445-8.

  23. MacKenzie A E, MD, PhD, Jacob P, MD, FRCP, Surth L, MD, PhD. Genetic heterogeneity in spinal muscular atrophy: A linkage analysis based assessment. Neurology 1994; 33: 419-924.

  24. Thompson TG, DiDonato C J, Simard LR. A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nature Genetics 1995; 9: 56-62.

  25. Schimdt R, Voit Th. Ultrasound measurement of quadriceps muscle in the first year of life. Normal values and application to spinal muscular atrophy. Neuropediatrics 1993; 24: 36-42.




2020     |     www.medigraphic.com